Arbutus Biopharma
ABUS
#7051
Rank
โ‚น57.10 B
Marketcap
โ‚น372.49
Share price
-1.23%
Change (1 day)
-3.53%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): โ‚น76.72

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is โ‚น75.98. In 2025 the company made an earnings per share (EPS) of -โ‚น15.75 an increase over its 2024 EPS that were of -โ‚น35.21.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น76.72-587.06%
2025-โ‚น15.75-55.26%
2024-โ‚น35.21-13.64%
2023-โ‚น40.77-4.35%
2022-โ‚น42.62-44.58%
2021-โ‚น76.91-17%
2020-โ‚น92.66-65.4%
2019-โ‚น267.79138.84%
2018-โ‚น112.12-22.44%
2017-โ‚น144.55-78.45%
2016-โ‚น670.86424.64%
2015-โ‚น127.87-20.19%
2014-โ‚น160.2387.96%
2013-โ‚น85.25-142.59%
2012โ‚น200.15-342.7%
2011-โ‚น82.47-25.82%
2010-โ‚น111.1747.8%
2009-โ‚น75.22-43.55%
2008-โ‚น133.24158.91%
2007-โ‚น51.46-111.88%
2006โ‚น433.25-552.53%
2005-โ‚น95.74-71.77%
2004-โ‚น339.15-14.48%
2003-โ‚น396.57-8.95%
2002-โ‚น435.5570.07%
2001-โ‚น256.1048.01%
2000-โ‚น173.02-38.54%
1999-โ‚น281.50-24.6%
1998-โ‚น373.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น5.56-107.32% Bahamas
NRC Health
NRC
โ‚น26.87-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA